DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring MELA Sciences Inc. (Nasdaq:MELA). The report briefly notes the company's most recent developments and news, and outlines its financial position, market performance, and comparison against industry peers.
The full report is available at: www.microstockprofit.com/lp/MELA
MELA Sciences (MELA) is a medical technology company focused on developing MelaFind, a non-invasive and objective multi-spectral computer vision system intended to aid in the detection of early melanoma. It designed MelaFind to assist in the evaluation of clinically atypical pigmented skin lesions, when a dermatologist chooses to obtain additional information before making a final decision to biopsy to rule out melanoma. MelaFind acquires and displays multi-spectral (from blue to near infrared) and reconstructed RGB digital images of pigmented skin lesions and uses automatic image analysis and statistical pattern recognition to help identify lesions to be considered for biopsy to rule out melanoma, the deadliest form of skin cancer. Although no cure is currently available for advanced-stage melanoma, melanoma is virtually 100% curable if caught early. By increasing the accuracy and reducing the invasiveness of early screening, MELA hopes to help improve early screening rates, reduce the number of unnecessary biopsies and help save lives.
This newsletter has been helping traders make great investment decisions on MELA; click here for a 25% discount offer.
In the report, the analyst notes:
"Shares rocketed 79% yesterday after the New York-based medical device developer said it secured regulatory approval to market its melanoma detection device MelaFind in the European Union (EU)."
"MELA intends to initially market its skin-cancer detecting device in Germany, which has the highest incidence of melanoma in Europe."
To read the entire report visit: www.microstockprofit.com/lp/MELA
See what investors are saying about MELA at http://www.stockhideout.com
Get breaking news on MELA at http://thestockmarketwatch.com
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.